{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:06:55Z","timestamp":1791295615048,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.ahj.2010.04.024","type":"journal-article","created":{"date-parts":[[2010,11,22]],"date-time":"2010-11-22T04:11:19Z","timestamp":1290399079000},"page":"915-921","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":110,"title":["Effect of eplerenone versus spironolactone on cortisol and hemoglobin A1c levels in patients with chronic heart failure"],"prefix":"10.1016","volume":"160","author":[{"given":"Masayuki","family":"Yamaji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayoshi","family":"Tsutamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiho","family":"Kawahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keizo","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Horie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6 Suppl","key":"10.1016\/j.ahj.2010.04.024_bb0005","first-page":"VI40","article-title":"Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group","volume":"87","author":"Francis","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2010.04.024_bb0010","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/0735-1097(94)90385-9","article-title":"Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: a report from the Registry of Studies of Left Ventricular Dysfunction. SOLVD Investigators","volume":"23","author":"Benedict","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2010.04.024_bb0015","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0735-1097(00)00796-8","article-title":"Spironolactone inhibits the transcardiac extraction of aldosterone in patients with congestive heart failure","volume":"36","author":"Tsutamoto","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2010.04.024_bb0020","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0735-1097(01)01116-0","article-title":"Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure","volume":"37","author":"Tsutamoto","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2010.04.024_bb0025","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2010.04.024_bb0030","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"issue":"7 Suppl 4","key":"10.1016\/j.ahj.2010.04.024_bb0035","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/00005344-200000004-00002","article-title":"Insulin resistance in chronic heart failure","volume":"35","author":"Coats","year":"2000","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.ahj.2010.04.024_bb0040","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1001\/jama.294.3.334","article-title":"Insulin resistance and risk of congestive heart failure","volume":"294","author":"Ingelsson","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2010.04.024_bb0045","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jacc.2008.08.081","article-title":"Insulin resistance is highly prevalent and is associated with reduced exercise tolerance in nondiabetic patients with heart failure","volume":"53","author":"AlZadjali","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2010.04.024_bb0050","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1001\/archinte.168.15.1699","volume":"168","author":"Gerstein","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2010.04.024_bb0055","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/00004872-200018110-00011","article-title":"The contribution of skeletal muscle tumor necrosis factor-alpha to insulin resistance and hypertension in fructose-fed rats","volume":"18","author":"Togashi","year":"2000","journal-title":"J Hypertens"},{"key":"10.1016\/j.ahj.2010.04.024_bb0060","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nature05483","article-title":"Adipocytes as regulators of energy balance and glucose homeostasis","volume":"444","author":"Rosen","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ahj.2010.04.024_bb0065","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1161\/01.HYP.0000036448.44066.53","article-title":"Angiotensin blockade prevents type 2 diabetes by formation of fat cells","volume":"40","author":"Sharma","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2010.04.024_bb0070","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/cvr\/cvp191","article-title":"Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice","volume":"84","author":"Hirata","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ahj.2010.04.024_bb0075","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/0002-9149(92)90904-D","article-title":"Cardiac characteristics and postoperative courses in Cushing's syndrome","volume":"69","author":"Sugihara","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2010.04.024_bb0080","first-page":"509","article-title":"Left ventricular structural characteristics in Cushing's syndrome","volume":"8","author":"Fallo","year":"1994","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.ahj.2010.04.024_bb0085","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1161\/CIRCULATIONAHA.106.653964","article-title":"Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure","volume":"115","author":"Guder","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2010.04.024_bb0090","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1161\/CIRCHEARTFAILURE.109.868513","article-title":"Serum Cortisol as a Useful Predictor of Cardiac Events in Patients With Chronic Heart Failure: The Impact of Oxidative Stress","volume":"2","author":"Yamaji","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ahj.2010.04.024_bb0095","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1210\/jcem-54-1-131","article-title":"Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action","volume":"54","author":"Rizza","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ahj.2010.04.024_bb0100","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1210\/jcem-57-3-529","article-title":"Insulin resistance in Cushing's syndrome","volume":"57","author":"Nosadini","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ahj.2010.04.024_bb0105","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.2337\/diabetes.54.4.1090","article-title":"Serum- and glucocorticoid-inducible kinase 1 (SGK1) mediates glucocorticoid-induced inhibition of insulin secretion","volume":"54","author":"Ullrich","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.ahj.2010.04.024_bb0110","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1677\/JOE-07-0462","article-title":"Sub-chronic stimulation of glucocorticoid receptor impairs and mineralocorticoid receptor protects cytosolic Ca2+ responses to glucose in pancreatic beta-cells","volume":"197","author":"Koizumi","year":"2008","journal-title":"J Endocrinol"},{"key":"10.1016\/j.ahj.2010.04.024_bb0115","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1161\/01.CIR.0000042707.50032.19","article-title":"Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice","volume":"106","author":"Okamoto","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2010.04.024_bb0120","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cca.2007.01.026","article-title":"Adiponectin as an anti-inflammatory factor","volume":"380","author":"Ouchi","year":"2007","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ahj.2010.04.024_bb0125","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","article-title":"The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity","volume":"7","author":"Yamauchi","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.ahj.2010.04.024_bb0130","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.2337\/diabetes.50.5.1126","article-title":"Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys","volume":"50","author":"Hotta","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.ahj.2010.04.024_bb0135","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1161\/CIRCULATIONAHA.104.530972","article-title":"Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure","volume":"112","author":"Kistorp","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2010.04.024_bb0140","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/eurheartj\/ehm154","article-title":"Total and high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart failure","volume":"28","author":"Tsutamoto","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2010.04.024_bb0145","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/clc.20324","article-title":"A comparison of the aldosterone-blocking agents eplerenone and spironolactone","volume":"31","author":"Struthers","year":"2008","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ahj.2010.04.024_bb0150","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1007\/s00125-004-1510-8","article-title":"Spironolactone impairs endothelial function and heart rate variability in patients with type 2 diabetes","volume":"47","author":"Davies","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.ahj.2010.04.024_bb0155","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/s00125-008-0972-5","article-title":"Spironolactone for poorly controlled hypertension in type 2 diabetes: conflicting effects on blood pressure, endothelial function, glycaemic control and hormonal profiles","volume":"51","author":"Swaminathan","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.ahj.2010.04.024_bb0160","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/01.CIR.96.2.509","article-title":"Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction","volume":"96","author":"Tsutamoto","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2010.04.024_bb0165","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0306-4530(00)00006-8","article-title":"Increased activity of the hypothalamus-pituitary-adrenal system after treatment with the mineralocorticoid receptor antagonist spironolactone","volume":"25","author":"Heuser","year":"2000","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ahj.2010.04.024_bb0170","first-page":"147","article-title":"Effect of single treatment with the antihypertensive drug eplerenone on hormone levels and anxiety-like behaviour in rats","volume":"42","author":"Hlavacova","year":"2008","journal-title":"Endocr Regul"},{"key":"10.1016\/j.ahj.2010.04.024_bb0175","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0022-3565(25)22580-0","article-title":"Three new epoxy-spirolactone derivatives: characterization in vivo and in vitro","volume":"240","author":"de Gasparo","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ahj.2010.04.024_bb0180","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1527-3466.2001.tb00064.x","article-title":"Eplerenone: a selective aldosterone receptor antagonist (SARA)","volume":"19","author":"Delyani","year":"2001","journal-title":"Cardiovasc Drug Rev"},{"key":"10.1016\/j.ahj.2010.04.024_bb0185","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/HJH.0b013e328326cb04","article-title":"Cardiac steroidogenesis and glucocorticoid in the development of cardiac hypertrophy during the progression to heart failure","volume":"27","author":"Ohtani","year":"2009","journal-title":"J Hypertens"},{"key":"10.1016\/j.ahj.2010.04.024_bb0190","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2337\/dc08-1709","article-title":"Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program","volume":"32","author":"Preiss","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahj.2010.04.024_bb0195","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0889-857X(05)70083-1","article-title":"Drug selection and the management of corticosteroid-related diabetes mellitus","volume":"25","author":"Hoogwerf","year":"1999","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.ahj.2010.04.024_bb0200","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.107.748640","article-title":"Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines","volume":"117","author":"Guo","year":"2008","journal-title":"Circulation"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870310006599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870310006599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:41:45Z","timestamp":1757569305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870310006599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0002870310006599"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2010.04.024","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of eplerenone versus spironolactone on cortisol and hemoglobin A1c levels in patients with chronic heart failure","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2010.04.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}